Adaptimmune Therapeutics
ADAP
#9424
Rank
HK$0.44 B
Marketcap
HK$1.74
Share price
-12.73%
Change (1 day)
-83.64%
Change (1 year)

Earnings for Adaptimmune Therapeutics (ADAP)

Earnings in 2024 (TTM): -HK$0.51 Billion

According to Adaptimmune Therapeutics's latest financial reports the company's current earnings are HK$0.17 Billion. , an increase over its 2023 earnings that were of -HK$0.88 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Adaptimmune Therapeutics from 2016 to 2024

Annual earnings

Year Earnings Change
2024 -HK$0.51 Billion-41.87%
2023 -HK$0.88 Billion-30.65%
2022 -HK$1.26 Billion-0.36%
2021 -HK$1.27 Billion21.62%
2020 -HK$1.04 Billion-4.55%
2019 -HK$1.09 Billion69%
2018 -HK$0.65 Billion-7.47%
2017 -HK$0.7 Billion24.71%
2016 -HK$0.56 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-HK$1.22 Billion 140.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$59.05 Million-88.34%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$1.96 Billion 286.58%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
HK$5.29 B-1,145.88%๐Ÿ‡บ๐Ÿ‡ธ USA